請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84231完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳美州(Mei-Jou Chen) | |
| dc.contributor.author | Cheng-Yu Ho | en |
| dc.contributor.author | 何鎮宇 | zh_TW |
| dc.date.accessioned | 2023-03-19T22:06:44Z | - |
| dc.date.copyright | 2022-10-13 | |
| dc.date.issued | 2022 | |
| dc.date.submitted | 2022-09-26 | |
| dc.identifier.citation | 1. Dun EC, Nezhat CH. Tubal factor infertility: diagnosis and management in the era of assisted reproductive technology. Obstetrics and gynecology clinics of North America.2012;39(4):551-66. Epub 2012/11/28. doi: 10.1016/j.ogc.2012.09.006. PubMed PMID:23182560. 2. Kotlyar A, Gingold J, Shue S, Falcone T. The Effect of Salpingectomy on Ovarian Function. Journal of minimally invasive gynecology. 2017;24(4):563-78. Epub 2017/02/23. doi:10.1016/j.jmig.2017.02.014. PubMed PMID: 28223181. 3. Spandorfer SD, Liu HC, Neuer A, Barmat LI, Davis O, Rosenwaks Z. The embryo toxicity of hydrosalpinx fluid is only apparent at high concentrations: an in vitro model that stimulates in vivo events. Fertility and sterility. 1999;71(4):619-26. Epub 1999/04/15. doi:10.1016/s0015-0282(98)00541-x. PubMed PMID: 10202869. 4. Chan LY, Chiu PY, Cheung LP, Haines CJ, Tung HF, Lau TK. A study of teratogenicity of hydrosalpinx fluid using a whole rat embryo culture model. Human reproduction (Oxford,England). 2003;18(5):955-8. Epub 2003/05/02. doi: 10.1093/humrep/deg189. PubMed PMID:12721168. 5. Chen CD, Yang JH, Lin KC, Chao KH, Ho HN, Yang YS. The significance of cytokines, chemical composition, and murine embryo development in hydrosalpinx fluid for predicting the IVF outcome in women with hydrosalpinx. Human reproduction (Oxford, England). 2002;17(1):128-33. Epub 2002/01/05. doi: 10.1093/humrep/17.1.128. PubMed PMID: 11756375. 6. Bedaiwy MA, Goldberg JM, Falcone T, Singh M, Nelson D, Azab H, et al. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Human reproduction (Oxford, England). 2002;17(3):601-4. Epub 2002/03/01. doi: 10.1093/humrep/17.3.601.PubMed PMID: 11870110. 7. Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertility and sterility. 1998;70(3):492-9. Epub 1998/10/03. doi: 10.1016/s0015-0282(98)00200-3. PubMed PMID: 9757878. 8. Melo P, Georgiou EX, Johnson N, van Voorst SF, Strandell A, Mol BWJ, et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. The Cochrane database of systematic reviews. 2020;10(10):Cd002125. Epub 2020/10/23. doi:10.1002/14651858.CD002125.pub4. PubMed PMID: 33091963; PubMed Central PMCID:PMCPMC8094448 gynaecologist at Auckland Gynaecology Group and Fertility Specialist at Repromed Auckland. Within the last 3 years NJ has had consultancy with Guerbet, Myovant Sciences, Vifor Pharma and Roche Diagnostics and has received research funding from Guerbet, AbbVie and Myovant Sciences. SVV ‐ at the time of the update in 2010 ‐ was a medical student of the faculty of Health, Medicine and Life Sciences of the University of Maastricht. She is now a resident in Obstetrics and Gynaecology at the Erasmus Medical Center, Rotterdam, the Netherlands. She has no financial conflicts of interest. AS led one of the trials included in this review (Strandell 1999). She is a gynaecologist at Sahlgrenska Hospital, associate professor at the University of Gothenburg and employed at the regional centre for Health Technology Assessment in Göteborg, Sweden. She has received fees from Guerbet for an expert consultancy. BWJM is an author on one of the trials included in this review (Dreyer 2016) and confirms he took no part in selecting this study, extracting data or assessing risk of bias. In addition, BWJM is supported by a NHMRC Investigator grant (GNT1176437) and reports consultancy for ObsEva, Merk KGaA, iGenomix and Guerbet. CMB has received research support by Bayer, Volition Rx, Roche Diagnostics and MDNA Life Sciences. He has also received consultancy fees from ObsEva, AbbVie and Myovant. IEG's institution has received research support from Finox and Bayer. 9. Volodarsky-Perel A, Buckett W, Tulandi T. Treatment of hydrosalpinx in relation to IVF outcome: a systematic review and meta-analysis. Reproductive biomedicine online. 2019;39(3):413-32. Epub 2019/07/22. doi: 10.1016/j.rbmo.2019.04.012. PubMed PMID: 31324437. 10. Zhang Y, Sun Y, Guo Y, Li TC, Duan H. Salpingectomy and proximal tubal occlusion for hydrosalpinx prior to in vitro fertilization: a meta-analysis of randomized controlled trials. Obstetrical & gynecological survey. 2015;70(1):33-8. Epub 2015/01/27. doi:10.1097/ogx.0000000000000139. PubMed PMID: 25616345. 11. Mohamed AA, Yosef AH, James C, Al-Hussaini TK, Bedaiwy MA, Amer S. Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta obstetricia et gynecologica Scandinavica. 2017;96(7):795-803. Epub 2017/05/05. doi: 10.1111/aogs.13133.PubMed PMID: 28471535. 12. Pereira N, Pryor KP, Voskuilen-Gonzalez A, Lekovich JP, Elias RT, Spandorfer SD, et al. Ovarian Response and in Vitro Fertilization Outcomes After Salpingectomy: Does Salpingectomy Indication Matter? Journal of minimally invasive gynecology. 2017;24(3):446-54.e1. Epub 2017/01/11. doi: 10.1016/j.jmig.2016.12.023. PubMed PMID: 28069482. 13. Chen T, Zhao F, Wang Q, Liu C, Lan Y, Wang S, et al. Salpingectomy may decrease antral follicle count but not live birth rate for IVF-ET patients aged 35-39 years: a retrospective study. Journal of ovarian research. 2020;13(1):80. Epub 2020/07/21. doi: 10.1186/s13048-020-00678-9. PubMed PMID: 32684158; PubMed Central PMCID: PMCPMC7370502. 14. ACOG Practice Bulletin No. 191: Tubal Ectopic Pregnancy. Obstetrics and gynecology.2018;131(2):e65-e77. Epub 2017/12/13. doi: 10.1097/aog.0000000000002464. PubMed PMID:29232273. 15. Luo J, Shi Y, Liu D, Yang D, Wu J, Cao L, et al. The effect of salpingectomy on the ovarian reserve and ovarian response in ectopic pregnancy: A systematic review and metaanalysis. Medicine. 2019;98(47):e17901. Epub 2019/11/26. doi:10.1097/md.0000000000017901. PubMed PMID: 31764787; PubMed Central PMCID: PMCPMC6882622. 16. Chan CC, Ng EH, Li CF, Ho PC. Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy. Human reproduction (Oxford, England). 2003;18(10):2175-80. Epub 2003/09/26. doi: 10.1093/humrep/deg411.PubMed PMID: 14507841. 17. Vignarajan CP, Malhotra N, Singh N. Ovarian Reserve and Assisted Reproductive Technique Outcomes After Laparoscopic Proximal Tubal Occlusion or Salpingectomy in Women with Hydrosalpinx Undergoing in Vitro Fertilization: A Randomized Controlled Trial.Journal of minimally invasive gynecology. 2019;26(6):1070-5. Epub 2018/10/27. doi:10.1016/j.jmig.2018.10.013. PubMed PMID: 30366115. 18. Atilgan R, Pala S, Kuloglu T, Sanli C, Yavuzkir S, Ozkan ZS. Comparison of the efficacy between bilateral proximal tubal occlusion and total salpingectomy on ovarian reserve and the cholinergic system: an experimental study. Turk J Med Sci. 2020;50(4):1097-105. Epub 20200623. doi: 10.3906/sag-2002-179. PubMed PMID: 32394684; PubMed Central PMCID:PMCPMC7379445. 19. Atilgan R, Kuloglu T, Boztosun A, Orak U, Baspinar M, Can B, et al. Investigation of the effects of unilateral total salpingectomy on ovarian proliferating cell nuclear antigen and follicular reserve: experimental study. Eur J Obstet Gynecol Reprod Biol. 2015;188:56-60.Epub 20150226. doi: 10.1016/j.ejogrb.2015.02.028. PubMed PMID: 25790915. 20. Huang CC, Chou CH, Chen SU, Ho HN, Yang YS, Chen MJ. Increased platelet factor 4 and aberrant permeability of follicular fluid in PCOS. Journal of the Formosan Medical Association = Taiwan yi zhi. 2019;118(1 Pt 2):249-59. Epub 2018/05/22. doi:10.1016/j.jfma.2018.05.002. PubMed PMID: 29779926. 21. Li H, He YL, Li R, Wong C, Sy B, Lam CW, et al. Age-specific reference ranges of serum anti-müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study. BJOG : an international journal of obstetrics and gynaecology. 2020;127(6):720-8. Epub 2020/02/06. doi: 10.1111/1471-0528.16147. PubMed PMID: 32009280. 22. Fan M, Ma L. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis. Fertility and sterility. 2016;106(2):322-9.e9. Epub 2016/04/27. doi: 10.1016/j.fertnstert.2016.03.053. PubMed PMID: 27114330. 23. Yoon SH, Lee JY, Kim SN, Chung HW, Park SY, Lee C. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles? Fertility and sterility. 2016;106(5):1083-92.e5. Epub 2016/06/24. doi: 10.1016/j.fertnstert.2016.05.030. PubMed PMID: 27336211. 24. Ye XP, Yang YZ, Sun XX. A retrospective analysis of the effect of salpingectomy on serum antiMullerian hormone level and ovarian reserve. Am J Obstet Gynecol. 2015;212(1):53 e1-10. Epub 20140718. doi: 10.1016/j.ajog.2014.07.027. PubMed PMID: 25046807. 25. Cui L, Sheng Y, Sun M, Hu J, Qin Y, Chen ZJ. Chronic Pelvic Inflammation Diminished Ovarian Reserve as Indicated by Serum Anti Mülerrian Hormone. PloS one.2016;11(6):e0156130. Epub 2016/06/09. doi: 10.1371/journal.pone.0156130. PubMed PMID:27272680; PubMed Central PMCID: PMCPMC4894572. 26. Chen MJ, Peng SS, Lu MY, Yang YL, Jou ST, Chang HH, et al. Effect of iron overload on impaired fertility in male patients with transfusion-dependent beta-thalassemia. Pediatric research. 2018;83(3):655-61. Epub 2017/11/23. doi: 10.1038/pr.2017.296. PubMed PMID: 29166371. 27. Chen MJ, Chou CH, Shun CT, Mao TL, Wen WF, Chen CD, et al. Iron suppresses ovarian granulosa cell proliferation and arrests cell cycle through regulating p38 mitogenactivated protein kinase/p53/p21 pathway. Biology of reproduction. 2017;97(3):438-48. Epub 2017/10/13. doi: 10.1093/biolre/iox099. PubMed PMID: 29024968. 28. Yang JH, Chou CH, Yang WS, Ho HN, Yang YS, Chen MJ. Iron stores and obesity are negatively associated with ovarian volume and anti-Müllerian hormone levels in women with polycystic ovary syndrome. Taiwanese journal of obstetrics & gynecology. 2015;54(6):686-92. Epub 2015/12/25. doi: 10.1016/j.tjog.2014.11.025. PubMed PMID: 26700986. 29. Tian Z, Zhang Y, Zhang C, Wang Y, Zhu HL. Antral follicle count is reduced in the presence of endometriosis: a systematic review and meta-analysis. Reproductive biomedicine online. 2021;42(1):237-47. Epub 2020/11/11. doi: 10.1016/j.rbmo.2020.09.014. PubMed PMID:3168492. 30. Hydrosalpinx and infertility: what about conservative surgical management?O. Chanelles et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 159 (2011) 122-126 31. Endometriosis III and IV as a risk factor for tubal obstruction in infertile women. JBRA Assisted Reproduction 2019;23(4):333-335 doi: 10.5935/1518-0557.20190004 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/84231 | - |
| dc.description.abstract | 輸卵管因素造成的不孕症所佔的比例約為所有因素綜合之30~40%,主要原因為骨盆腔感染造成的輸卵管炎、子宮內膜異位症或外科手術造成的沾黏阻塞及水腫,亦可間接造成子宮外孕。而過去文獻於1998年Zeyneloglu.等人表示,預防性將水腫的輸卵管切除可提高試管嬰兒成功率以及降低流產率。體外胚胎活體的實驗也證明水腫的輸卵管會影響子宮內膜胚胎著床的機轉。 然而,將輸卵管切除後是否對於卵巢功能及之後進入取卵療程的結果有影響,過去則一直有爭議。由於影響卵巢的因素主要有年紀、卵巢手術、子宮內膜異位症、多囊性卵巢等因素,2020年由Chen.等人發表於journal of ovarian research的研究探討女性年齡35 至39歲顯示基礎濾泡數(AFC)可能因為輸卵管手術而下降,但缺乏較年輕不孕症族群的比較以及其他衡量卵巢功能之指標比較。因此本研究欲探討35歲以下的不孕症患者其先前曾接受過輸卵管手術後,對其取卵數目之影響。2003年於Human reproduction 雜誌表示子宮外孕病人的輸卵管切除對於卵巢的大小及供應血流有顯著影響,而2015-2017年四篇 meta-analysis皆認為手術不會對卵巢有影響,但是研究異質性高,主要針對輸卵管水腫病人,而且術後長期追蹤結果未明。因此於新光醫院收集2012-2019年間的輸卵管因素的不孕試管病人,為降低年齡對於卵巢功能本身之影響。研究對象為年紀35歲以下接受取卵手術者,以曾接受輸卵管手術與否分組,並控制Age、BMI、卵巢功能指標(AMH 及AFC)、使用排卵刺激藥物劑量及刺激天數,來探討其經陰道取卵手術的結果(取卵數目)差異。 本研究為病例回溯性研究,病例及對照研究,病例資料取得以健保資料手術代碼(腹腔鏡輸卵管等附屬器切除術、子宮外孕手術以及經陰道取卵手術)委由新光醫院資訊部人員查詢,先取得病歷號資料並交由本案主持人,由主持人借閱紙本病歷,並篩選,經確定收案後即去除識別化資料(如病歷號、姓名),之後依阿拉伯數字編碼分為研究組及對照組,過程中再將已去識別化的資料交由本案統計分析人員分析。本計畫最後收案對象以2012年1月1日至2019年12月31日,期間接受取卵手術時,35歲以下之不孕症病人,一共113人,且過去有接受過輸卵管切除術者為實驗組(54人),其中包含輸卵管外孕及水腫。而對照組為相同年紀配對之男性不孕及不明原因不孕症之患者(59人)。我們主要比較其進入刺激排卵療程之結果。如總取卵數目、總排卵針劑量及刺激天數。 本研究以無母數分析方法,比較有無接受輸卵管手術的兩組,其術後第一次取卵手術之取卵數目、排卵針使用劑量、刺激天數。並校正BMI、day 3 FSH值、術前AMH及AFC等因子。再由線性回歸分析找出顯著影響取卵數目之因子,如AMH及AFC。再參考過去文獻以及對照本實驗之族群決定所選因子之臨界值(cut-off value)。然後依臨界值進一步做次群組分析(sub-group analysis)。 本研究納入於接受取卵手術時年齡為35歲以下之不孕症患者,實驗組包含曾接受輸卵管切除術的不孕病人54位,而輸卵管切除術的適應症有輸卵管外孕26位以及輸卵管水腫28位。對照組則包含男性因素及不明原因之不孕症一共56位;若曾接受過卵巢手術、患有子宮內膜異位症或多囊性卵巢者則排除於此研究。 結論及討論 : 在35歲以下較為年輕的不孕症患者,因輸卵管問題造成的不孕,不論是先前子宮外孕或是輸卵管水腫的原因,在經過輸卵管手術切除後,與輸卵管正常的不孕症族群相比,其試管療程的取卵數目顯著下降;而其中取卵前的卵巢功能指標次佳者如AFC <12 或是AMH <4 ng/mL者,則取卵數顯著下降。因此在有接受過輸卵管手術的年輕不孕症患者,若非有絕佳的卵巢功能指標則可考慮積極地使用刺激排卵試管嬰兒療程。本研究亦嘗試討論手術間隔、輸卵管切除的側性對於卵巢反應的影響,但由於樣本數較少故無一致性的結論。 | zh_TW |
| dc.description.abstract | Study Objective: The impairment of the ovarian response in in vitro fertilization (IVF) cycles after salpingectomy remains controversial. Therefore, we investigated whether a history of salpingectomy affects the number of oocytes retrieved in young women undergoing IVF in comparison with the number in women without the underlying tubal disease. We also considered the factors affecting the ovarian response as separate groups, such as indications of salpingectomy, laterality of salpingectomy, and the time interval between tubal surgery and oocyte retrieval. Design: Retrospective Case-control study (Canadian Task Force Classification II-2) Setting: A tertiary hospital–affiliated fertility center. Patients: We recruited patients under the age of 35 from 2012 to 2019, which received salpingectomies and entered IVF treatment afterward. Only Fifty-four women aged <35 years with a history of salpingectomy and 59 age-matched women without tubal disease. Interventions: Laparoscopic salpingectomy, Gonadotropin-releasing hormone antagonist protocol for controlled ovarian stimulation and transvaginal oocyte retrieval. Measurements and Main Results:The antral follicle count (AFC), anti-Müllerian hormone (AMH) levels, and the number of retrieved oocytes were significantly lower in women with prior salpingectomy than in women without tubal disease. Day-3 follicle-stimulating hormone (FSH) levels, total gonadotropin dosage, and stimulation days did not significantly differ between the groups. The indications of salpingectomy (i.e., hydrosalpinx and ectopic pregnancy) did not differ significantly in terms of ovarian response or reserve among women with salpingectomy history. A history of salpingectomy and other factors related to ovarian response in IVF, such as age, AMH, AFC, day-3 FSH, and total gonadotropin dose, were significantly correlated with the number of oocytes retrieved by univariate regression analysis. In the multivariate-adjusted model after controlling all the above-mentioned variables, only AFC and AMH levels continued to exhibit significant associations with the number of retrieved oocytes. In a subgroup analysis, the negative impact of prior salpingectomy on the number of retrieved oocytes was especially significant in women with suboptimal ovarian reserves (defined as AMH < 4 ng/mL), regardless of the indication of salpingectomy or whether salpingectomy was bilateral or unilateral. Conclusion:A negative effect on the number of retrieved oocytes in the subsequent IVF cycle after salpingectomy is more likely in women aged <35 years with suboptimal ovarian reserve. Nevertheless, postsurgical AMH and AFC levels still possess a more direct predictive value on ovarian response than the history of salpingectomy. | en |
| dc.description.provenance | Made available in DSpace on 2023-03-19T22:06:44Z (GMT). No. of bitstreams: 1 U0001-2509202212074700.pdf: 6034180 bytes, checksum: 2d4a2456b9ecd1c690b1d2041ed8c807 (MD5) Previous issue date: 2022 | en |
| dc.description.tableofcontents | 口試委員會審定書...............................................2 誌謝..........................................................3 中文摘要......................................................4 英文摘要......................................................6 目錄..........................................................8 圖表目錄......................................................10 Chapter 1 Introduction.......................................11 1.1 Overview of tubal-factor infertility.....................11 1.2 Overview of tubal surgery................................12 1.3 The effect of hydrosalpinges on IVF outcome..............13 1.4 Impact of tubal surgery on ovarian function from the review of literature.....14 1.5 Measurements of ovarian response..............................................16 1.6 Aim of the study..............................................................18 Chapter 2 Material and methods....................................................18 2.1 Setting and design............................................................18 2.2 Diagnosis of tubal infertility................................................19 2.3 Salpingectomy.................................................................20 2.4 Controlled ovarian stimulation and outcome measures...........................21 2.5 Statistical analysis..........................................................22 Chapter 3 Results.................................................................22 3.1 Participants..................................................................22 3.2 Demographics, baseline characteristics, and hormonal profiles.................23 3.3 Outcomes......................................................................24 3.4 Subgroup analysis.............................................................24 3.5 Choices of cut-off value toward ovarian function..............................25 Chapter 4 Discussion..............................................................25 4.1 Innovation and main finding...................................................25 4.2 Studies regarding salpingectomy and ovarian function..........................26 4.3 Limitation of the study.......................................................29 4.4 Conclusion....................................................................30 References........................................................................31 Tables and Figures................................................................36 附錄:就讀期間發表之論文連結、人體試驗委員會證明書.....................................44 | |
| dc.language.iso | zh-TW | |
| dc.subject | 卵巢功能 | zh_TW |
| dc.subject | 試管嬰兒 | zh_TW |
| dc.subject | 抗穆勒氏荷爾蒙 | zh_TW |
| dc.subject | 輸卵管切除術 | zh_TW |
| dc.subject | 基礎濾泡數 | zh_TW |
| dc.subject | in vitro fertilization | en |
| dc.subject | ovarian reserve | en |
| dc.subject | salpingectomy | en |
| dc.subject | ovarian response | en |
| dc.subject | tubal infertility | en |
| dc.subject | antral follicle count | en |
| dc.subject | anti-Müllerian hormone | en |
| dc.title | 輸卵管切除術對於年輕不孕症患者卵巢反應之影響 | zh_TW |
| dc.title | The effect of salpingectomy on ovarian response among young infertile patients | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 110-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.author-orcid | 0000-0002-7895-3798 | |
| dc.contributor.oralexamcommittee | 陳沛隆(Pei-Lung Chen),張文君(Wen-Chun Chang) | |
| dc.subject.keyword | 輸卵管切除術,試管嬰兒,抗穆勒氏荷爾蒙,基礎濾泡數,卵巢功能, | zh_TW |
| dc.subject.keyword | salpingectomy,anti-Müllerian hormone,antral follicle count,ovarian reserve,ovarian response,tubal infertility,in vitro fertilization, | en |
| dc.relation.page | 45 | |
| dc.identifier.doi | 10.6342/NTU202203996 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2022-09-27 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| dc.date.embargo-lift | 2022-10-13 | - |
| 顯示於系所單位: | 臨床醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-2509202212074700.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 5.89 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
